<DOC>
	<DOCNO>NCT00280436</DOCNO>
	<brief_summary>This study design find optimal ( best ) dose GW679769 promote sleep onset maintain sleep two consecutive night dose without significant next-day thinking impairment drowsiness subject primary insomnia .</brief_summary>
	<brief_title>Effects Of GW679769 On Sleep Onset And Maintenance , And Next Day Functioning In The Elderly And Non-elderly With Primary Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Casopitant</mesh_term>
	<criteria>Difficulty go sleep and/or stay asleep least past 3 month . Insomnia must result significant distress impairment function home , socially work . Otherwise good health significant unstable medical disorder include psychiatric , neurological , endocrine , heart , lung gastrointestinal disorder , drug/alcohol abuse , cognitive impairment , cancer chronic pain condition arthritis . History sleep disorder sleep apnea restless leg syndrome . Regular sleep habit , include bedtime 9 PM midnight . Nightshift/rotating shift work , frequent napping plan travel across &gt; 2 time zone . Use moderate use nicotine , caffeine alcoholic product .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>April 2015</verification_date>
	<keyword>Polysomnography</keyword>
	<keyword>Electroencephalography</keyword>
	<keyword>Primary Insomnia</keyword>
	<keyword>Cognition</keyword>
	<keyword>Sleep</keyword>
</DOC>